These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34626189)

  • 1. High shock impedance during subcutaneous implantable defibrillator generator replacements.
    Maass AH; Groenveld HF; Mulder BA; Blaauw Y; Rienstra M
    Europace; 2022 Feb; 24(2):349-350. PubMed ID: 34626189
    [No Abstract]   [Full Text] [Related]  

  • 2. High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors' reply.
    van der Stuijt W; Smeding L; Knops RE
    Europace; 2022 Feb; 24(2):350-351. PubMed ID: 34626183
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between high- and low-voltage impedance measurements following subcutaneous implantable cardioverter-defibrillator implantation.
    Sink J; Peigh G; Speakman B; Banno J; Sanders D; Nso N; Waits G; Lohrmann G; Elsayed M; Carneiro H; Baman J; Pfenniger A; Patil KD; Arora R; Kim SS; Chicos AB; Lin AC; Passman RS; Knight BP; Dandamudi S; Kaplan RM; Huang H; Wasserlauf J; Verma N
    Heart Rhythm; 2024 Apr; 21(4):492-494. PubMed ID: 38159788
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-voltage shock impedance measurements: A false sense of security.
    Parwani AS; Lacour P; Franke P; Reichert U; Christoph K; Beiert T; Supryn R; Rangasamy K; Kull T; Hohendanner F; Heinzel F; Kucher A; Boldt LH; Pieske B; Blaschke F
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):93-100. PubMed ID: 33140439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing.
    Payne JE; Badertscher P; Field ME; Sturdivant JL; Gold MR
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008631. PubMed ID: 32703008
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.
    Amin AK; Gold MR; Burke MC; Knight BP; Rajjoub MR; Duffy E; Husby M; Stahl WK; Weiss R
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006665. PubMed ID: 30917689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular technique.
    Okabe T; Savona SJ; Matto F; Ward C; Singh P; Afzal MR; Kalbfleisch SJ; Weiss R; Houmsse M; Augostini RS; Hummel JD; Daoud EG
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3027-3034. PubMed ID: 34554620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leakage of energy to the body surface during defibrillation shock by an implantable cardioverter-defibrillator (ICD) system--experimental evaluation during defibrillation shocks through the right ventricular lead and the subcutaneous active-can in canines.
    Niwano S; Kitano Y; Moriguchi M; Yoshizawa N; Kashiwa T; Suyama M; Toyoshima T; Izumi T
    Jpn Circ J; 2001 Mar; 65(3):219-25. PubMed ID: 11266198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique.
    Francia P; Adduci C; Angeletti A; Ottaviano L; Perrotta L; De Vivo S; Bongiorni MG; Migliore F; Russo AD; De Filippo P; Caravati F; Nigro G; Palmisano P; Viani S; D'Onofrio A; Lovecchio M; Valsecchi S; Ziacchi M
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1695-1703. PubMed ID: 33969578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity.
    Quast ABE; van Dijk VF; Yap SC; Maass AH; Boersma LVA; Theuns DA; Knops RE
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1010-1016. PubMed ID: 29626366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling Study.
    Heist EK; Belalcazar A; Stahl W; Brouwer TF; Knops RE
    JACC Clin Electrophysiol; 2017 Apr; 3(4):405-414. PubMed ID: 29759454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature failure of a Riata defibrillator lead without impedance change or inappropriate sensing: a case report and review of the literature.
    Krebsbach A; Alhumaid F; Henrikson CA; Calkins H; Berger RD; Cheng A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):1070-2. PubMed ID: 21385268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications.
    Winter J; Siekiera M; Shin DI; Meyer C; Kröpil P; Clahsen H; O'Connor S
    Europace; 2017 Dec; 19(12):2036-2041. PubMed ID: 28007749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
    Prudente LA
    Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
    [No Abstract]   [Full Text] [Related]  

  • 15. Inappropriate shock because of triple counting in a patient with a subcutaneous implantable cardioverter defibrillator corrected by initiation of dual site left ventricular pacing.
    van Gelder BM; Bracke FA; Simmers T
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):239-40. PubMed ID: 25691559
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH; Van Gelder IC
    Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
    [No Abstract]   [Full Text] [Related]  

  • 17. The PRAETORIAN score: guardian against subcutaneous implantable cardioverter-defibrillator shock failure?
    Boersma LVA
    Europace; 2020 Dec; 22(12):1761-1762. PubMed ID: 33236073
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous Implantable Cardioverter Defibrillator: Early Experience.
    Souza FSO; Matos VS; Almeida MCV; Weiss SC; Rodrigues LHB; Lima PAG; Mattos DB
    Braz J Cardiovasc Surg; 2017; 32(6):498-502. PubMed ID: 29267613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract]   [Full Text] [Related]  

  • 20. Committed function for the first delivered shock of an uncommitted implantable cardioverter-defibrillator.
    Stroobandt RX; Barold SS
    Cardiol J; 2011; 18(5):570-2. PubMed ID: 21947997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.